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Here, we report and investigate the genomic alterations of two novel cases of Non-Hodgkin Lymphoma (NHL)
in children with Williams-Beuren syndrome (WBS), a multisystem disorder caused by 7q11.23 hemizygous deletion.
Additionally, we report the case of a child with NHL and a somatic 7q11.23 deletion. Although the WBS critical
region has not yet been identified as a susceptibility locus in NHL, it harbors a number of genes involved in DNA
repair. The high proportion of pediatric NHL reported in WBS is intriguing. Therefore, the role of haploinsufficiency
of genes located at 7q11.23 in lymphomagenesis deserves to be investigated.
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Chromosomal disorders are common circumstances for
the discovery of a genetic predisposition to cancer allowing
identification and localization of new oncogenes. Williams-
Beuren syndrome (WBS) is a multisystem disorder caused
by 7q11.23 hemizygous microdeletion [1]. WBS is not
currently considered as a risk factor for cancer. However,
the low incidence of both WBS and pediatric NHL (Non-
Hodgkin Lymphoma) might hamper our ability to identify
any association between these rare diseases. An increased
risk of NHL in WBS might have easily been under-
estimated until today. Furthermore, the number of pediatric
cancer reported in WBS has reached 11 cases and,
strikingly, 8 (73%) of them where NHL, mostly Burkitt
lymphoma (Table 1). Here, we report 2 novel cases of
NHL in children with WBS and the additional case of a
non-WBS child with NHL and somatic 7q11.23 deletion
(see case description in Additional file 1).* Correspondence: david.guenat@univ-fcomte.fr
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unless otherwise stated.Since several different deletions account for the genotype
of WBS, we first investigated germline and somatic struc-
tural variants in these latest 3 patients using array-based
CGH (Figure 1). We confirmed the presence of a constitu-
tional 7q11.23 deletion in WBS patients. No germline
Copy Number Variation (CNV) was observed in patient 3.
Intriguingly, the somatically acquired 7q11.23 deletion that
occurred in lymphoma of patient 3 was similar to the clas-
sical germline deletion observed in WBS patients and there
was no evidence of other rearrangements occurred in this
tumor. Lymphoma cells of WBS patients exhibited CNV
commonly found in B cell lymphoma excepting a subclo-
nal deletion of approximately 10 Mb at the locus 2q33.1-
q35 involving IKZF2 in WBS patient 2. A recent study by
Holmfeldt et al. demonstrated that this deletion was com-
mon in low-hypodiploid acute lymphoblastic leukemia [11]
but this deletion had never been described in NHL. Then,
next generation sequencing of the WBS region showed
a germline homozygous variant in exon 25 of ELN
(c.1741G > C, p.Gly581Arg, rs.17855988) in the 2 WBS
patients. ELN encodes elastin, a constituent of elastic fi-
bers. Many variants of ELN has been described and were
associated to the severity of cardiovascular symptoms of
WBS patients. No recurrent variant was observed in theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 List of pediatric cancers reported in WBS patients
Study Samples Authors Date of publication Age (years), gender Type of tumor Reference
1 WBS Patient 1 Guenat D TS 7, F NHL (Burkitt) -
2 WBS Patient 2 Guenat D TS 10, M NHL (B-NHL stage IV) -
3 - Vanhapiha N 2014 7, M NHL (Burkitt) and Ewing sarcoma [2]
4 - Chonan M 2013 3, M Astrocytoma [3]
5 - Zhukova N 2013 8, M NHL (Burkitt) [4]
6 - Onimoe G 2011 10, F NHL (Burkitt) [5]
7 - Urisarri Ruiz A 2008 12, M NHL (T-cell) [6]
8 - Thornburg CD 2005 1,? NHL (Burkitt) [7]
9 - Amenta S 2004 8, M NHL (Burkitt) [8]
10 - Culic V 2002 14, M ALL [9]
11 - Semmekrot BA 1985 5, ? Astrocytoma [10]
TS: This Study; NHL: Non-Hodgkin Lymphoma; ALL: Acute Lymphoblastic Leukemia, F: female; M: male.
Figure 1 Array-based comparative genomic hybridization analysis of normal tissues and lymphoma cells of 2 WBS patients and of a
third child without WBS but with NHL and a somatic 7q11.23 deletion. A. Typical hemizygous loss of the WBS region on chromosome
7q11.23 spanning 1.5 Mb was observed in normal and tumor DNA of 2 patients with WBS. Patient 3 had the same deletion in lymphoma cells
but this deletion was somatic. B. Study of somatic chromosomal rearrangements showed a homozygous deletion encompassing chromosome
band 9p21.3 at the INK4a/ARF locus on the tumor of patient 1. WBS patient 2 exhibited a large subclonal deletion on chromosomal region
2q33.2-q34 encompassing the IKZF2 gene locus and an amplification of a 10 Mb region at the locus 13q31.2-q31.3 involving MIR17HG. Patient 3
had no other chromosomal rearrangements in the tumor. PBMC: Peripheral Blood Mononuclear Cells.
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A number of genes mapping to the WBS region are
involved in DNA repair: 1) Eleven PMS2 pseudogenes
loci are located at 7q11.23. PMS2 plays a crucial role in
the DNA Mismatch Repair and a childhood cancer syn-
drome is associated to biallelic mutations of PMS2 [12].
However, in our study the 3 patients showed stable
microsatellites (Additional file 2); 2) BAZ1B encodes a
transcription factor with an intrinsic tyrosine kinase
domain that phosphorylates Tyr142 of histone H2A.X
and is involved in the maintaining of gH2A.X in the
sites of DNA damages [13]; 3) RFC2 encodes a subunit
of the Replication Factor C complex that interacts with
BRCA1 for post replication repair after UV-induced DNA
damage [14]; 4) GTF2I encodes a transcription factor
that promotes DNA translesion synthesis and genomic
stability interacting with PCNA and DNA polymerases
[15]. Finally, the hypothesis of a constitutional genomic
instability in WBS is consistent with the results of a
study by Savina et al. that showed experimentally the
relationship between an abnormal DNA-damage re-
sponse and the 7q11.23 hemizygous microdeletion
when comparing the comet assay data in FISH-
positive and FISH-negative lymphocytes from WBS-
suspected patients [16].
7q11.23 deletion has been found as a relatively com-
mon occurrence in pilocytic astrocytoma [17], of which
variants have been reported in 2 patients with WBS
[3,10]. Nevertheless, genome-wide copy number ana-
lysis in NHL, including a recent study by Conde et al.
that analyzed 648 patients, ages 20 to 85 years, have not
found a susceptibility locus at 7q11.23 [18]. However,
NHL in adults encompasses a heterogeneous spectrum
of diseases in which diffuse large B-cell lymphoma pre-
dominates. NHL in children is a more rare event and
pediatric DLBCL is uncommon. Burkitt lymphoma that
predominates in pediatric NHL, has also been studied
by genome-wide CNV studies. Notably, Scholtysik et al.
demonstrated a recurrent loss at 7q11.22, localized at
the centromeric limit of the WBS critical region, in 39
cases of BL [19]. Amplifications of the WBS critical
region have also been found in a variety of cancers
including large B-cell lymphoma [20], ovarian adeno-
carcinoma [21], papillary thyroid carcinoma [22] and
cholangiocarcinoma [23]. This might reflect complex
mechanisms that regulate initiation/promotion of cancer
cells by oncogenes and tumor suppressor genes clustered
around recombination hot spots or fragile sites in the
WBS region.
Althought no epidemiological studies demonstrated an
increased risk of cancer in WBS the high proportion of
pediatric NHL reported in WBS and the occurrence of a
somatic deletion of 7q11.23 in NHL is intriguing. Inthese patients, NHL seems to arise in the presence of
the typical WBS microdeletion and in the absence of
homozygous mutation. The role of haploinsufficiency
of genes located at 7q11.23 in lymphomagenesis de-
serves to be investigated.
Additional files
Additional file 1: Supplementary materials and methods [24].
Additional file 2: Study of microsatellites instability by capillary
electrophoresis fragment analysis. All patients have stables
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